Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2004;104:30-36
© 2004 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goetzl, L.
Right arrow Articles by Wapner, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goetzl, L.
Right arrow Articles by Wapner, R. J.
Related Collections
Right arrow Epidemiology/public health
Right arrow Genetics and teratology
Right arrow Prenatal Diagnosis

ORIGINAL RESEARCH

Pregnancy-Associated Plasma Protein A, Free ß-hCG, Nuchal Translucency, and Risk of Pregnancy Loss

Laura Goetzl, MD, MPH, David Krantz, Joe Leigh Simpson, MD, Richard K. Silver, MD, Julia M. Zachary, Eugene Pergament, MD, PhD, Lawrence D. Platt, MD, Maurice J. Mahoney, MD, JD and Ronald J. Wapner, MD BUN Study Group*

From Baylor College of Medicine, Houston, Texas; NTD Laboratories, Huntington Station, New York; The Fetal Diagnostic Center, Evanston Hospital, Evanston, Illinois; Northwestern University Medical School, Chicago, Illinois; George Washington Biostatistics Center, Washington, DC; Cedars Sinai Medical Center, Los Angeles, California; Yale University, New Haven, Connecticut; and Drexel University College of Medicine, Philadelphia, Pennsylvania.

OBJECTIVE: To estimate the likelihood of clinical early and late pregnancy loss as a function of first-trimester maternal serum analytes and fetal nuchal translucency measurements.

METHODS: Study subjects were recruited for a National Institute of Child Health and Human Development–sponsored multicenter cohort study initially designed to study the detection of Down syndrome during the first trimester of pregnancy. The cohort consisted of women who had a live fetus between 10 and 14 weeks of gestation and had no significant vaginal bleeding. Women with prior fetal trisomy (T21/18) and those with structural or chromosomal abnormalities in the index pregnancy were excluded. First-trimester screening consisted of pregnancy-associated plasma protein A (PAPP-A), free ß-hCG, and nuchal translucency. Pregnancy loss rates in women with various levels of PAPP-A, free ß-hCG, or nuchal translucency (less than 1st, less than 5th, more than 95th, and more than 99th percentile) were compared with losses in women with normal values (5th to 95th percentile).

RESULTS: The mean gestational age at screening of 7,932 women meeting study criteria was 12.1 weeks. Loss rates were only 0.36% at less than 20 weeks after normal free ß-hCG, PAPP-A, and nuchal translucency. Conversely, low levels of PAPP-A and free ß-hCG as well as increased nuchal translucency were individually associated with increased early loss. These associations persisted after controlling for maternal age and race using logistic regression analysis.

CONCLUSION: Normal values of PAPP-A, free ß-hCG, and nuchal translucency are associated with a very low risk of pregnancy loss at less than 20 weeks.

LEVEL OF EVIDENCE: II-2




This article has been cited by other articles:


Home page
 JWatch Women's HealthHome page
Normal Serum Analytes? Low Pregnancy Loss Rate
Journal Watch Women's Health, August 24, 2004; 2004(824): 6 - 6.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Obstetricians and Gynecologists.